BRCA2 3ʹ-UTR Polymorphism rs15869 Alters Susceptibility to Papillary Thyroid Carcinoma via Binding hsa-mir-1178-3p

References

• Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al. Global, Regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 Cancer Groups, 1990 to 2016: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2018;4(11):1553–1568. doi:10.1001/jamaoncol.2018.2706
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011;5(1):51–56. doi:10.1007/s12105-010-0236-9
   PubMedGoogle Scholar
• Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783–2795. doi:10.1016/S0140-6736(16)30172-6
   PubMed Web of Science ®Google Scholar
• Albi E, Cataldi S, Lazzarini A, et al. Radiation and thyroid cancer. Int J Mol Sci. 2017;18:5. doi:10.3390/ijms18050911
   Web of Science ®Google Scholar
• Broustas CG, Lieberman HB. DNA damage response genes and the development of cancer metastasis. Radiat Res. 2014;181(2):111–130. doi:10.1667/RR13515.1
   PubMed Web of Science ®Google Scholar
• Symington LS, Gautier J. Double-strand break end resection and repair pathway choice. Annu Rev Genet. 2011;45:247–271. doi:10.1146/annurev-genet-110410-132435
   PubMed Web of Science ®Google Scholar
• Burma S, Chen BP, Chen DJ. Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst). 2006;5(9–10):1042–1048. doi:10.1016/j.dnarep.2006.05.026
   PubMed Web of Science ®Google Scholar
• Akulevich NM, Saenko VA, Rogounovitch TI, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer. 2009;16(2):491–503. doi:10.1677/ERC-08-0336
   PubMed Web of Science ®Google Scholar
• Fayaz S, Karimmirza M, Tanhaei S, Fathi M, Torbati PM, Fard-Esfahani P. Increased risk of differentiated thyroid carcinoma with combined effects of homologous recombination repair gene polymorphisms in an Iranian population. Asian Pac J Cancer Prev. 2014;14(11):6727–6731. doi:10.7314/APJCP.2013.14.11.6727
   Google Scholar
• Gomes BC, Silva SN, Azevedo AP, et al. The role of common variants of non-homologous end-joining repair genes XRCC4, LIG4 and Ku80 in thyroid cancer risk. Oncol Rep. 2010;24(4):1079–1085.
   Web of Science ®Google Scholar
• Lahtz C, Pfeifer GP. Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol. 2011;3(1):51–58. doi:10.1093/jmcb/mjq053
   Web of Science ®Google Scholar
• Chou CK, Liu RT, Kang HY. MicroRNA-146b: a novel biomarker and therapeutic target for human papillary thyroid cancer. Int J Mol Sci. 2017;18(3). doi:10.3390/ijms18030636
   Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20. doi:10.1016/j.cell.2004.12.035
   PubMed Web of Science ®Google Scholar
• Teo MT, Landi D, Taylor CF, et al. The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis. 2012;33(3):581–586. doi:10.1093/carcin/bgr300
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Eskandari E, Rezaifar A, Hashemi M. XPG Asp1104His, XRCC2 rs3218536 A/G and RAD51 135G/C gene polymorphisms and colorectal cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2017;18(7):1805–1813. doi:10.22034/APJCP.2017.18.7.1805
   Google Scholar
• Krivokuca AM, Cavic MR, Malisic EJ, et al. Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women. Int J Biol Markers. 2016;31(3):e258–e263. doi:10.5301/jbm.5000201
   Web of Science ®Google Scholar
• Cypriano AS, Alves G, Ornellas AA, et al. Relationship between XPD, RAD51, and APEX1 DNA repair genotypes and prostate cancer risk in the male population of Rio de Janeiro, Brazil. Genet Mol Biol. 2017;40(4):751–758. doi:10.1590/1678-4685-gmb-2017-0039
   Web of Science ®Google Scholar
• Gudmundsdottir K, Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene. 2006;25(43):5864–5874. doi:10.1038/sj.onc.1209874
   PubMed Web of Science ®Google Scholar
• Lax SF. Hereditary breast and ovarian cancer. Pathologe. 2017;38(3):149–155. doi:10.1007/s00292-017-0298-5
   Web of Science ®Google Scholar
• Sirisena ND, Adeyemo A, Kuruppu AI, Samaranayake N, Dissanayake VHW. Genetic variants associated with clinicopathological profiles in sporadic breast cancer in Sri Lankan Women. J Breast Cancer. 2018;21(2):165–172. doi:10.4048/jbc.2018.21.2.165
   Web of Science ®Google Scholar
• Huang L, Wu C, Yu D, et al. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. Carcinogenesis. 2013;34(5):1001–1005. doi:10.1093/carcin/bgt004
   Web of Science ®Google Scholar
• Zbuk K, Xie C, Young R, et al. BRCA2 variants and cardiovascular disease in a multi-ethnic study. BMC Med Genet. 2012;13:56. doi:10.1186/1471-2350-13-56
   Web of Science ®Google Scholar
• Cao J, Luo C, Yan R, et al. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility. Med Oncol. 2016;33(12):135. doi:10.1007/s12032-016-0849-2
   Web of Science ®Google Scholar
• Song L, Dai T, Xie Y, et al. Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair. J Mol Cell Biol. 2012;4(2):108–117. doi:10.1093/jmcb/mjr046
   PubMed Web of Science ®Google Scholar
• Cao Z, Xu J, Huang H, et al. MiR-1178 promotes the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells by targeting CHIP. PLoS One. 2015;10(1):e0116934. doi:10.1371/journal.pone.0116934
   Web of Science ®Google Scholar
• Liu H, Bi J, Dong W, et al. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis. Mol Cancer. 2018;17(1):161. doi:10.1186/s12943-018-0908-8
   PubMed Web of Science ®Google Scholar
• Bi J, Liu H, Dong W, et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2019;18(1):133. doi:10.1186/s12943-019-1060-9
   PubMed Web of Science ®Google Scholar